Introduction
Introduction Statistics Contact Development Disclaimer Help
DTIC ADA463301: AR-NcoR Interaction as a Therapeutic Target for Pro...
by Defense Technical Information Center
Thumbnail
Download
Web page
Aim 1 is to determine the precise molecular basis for
NCoR binding to the RU486 liganded AR. Since the previous
report we have used chromatin immunoprecipitation to
demonstrate that RU486 enahnces AR NCoR recruitment to AR
assembled on androgen regulated genes. We have also
generated the additional AR and NCoR mutants to define
the precise amino acids mediating the interaction. Aim 2
is to determine whether NCoR recruitment can suppress
androgen independent expression of AR regulated genes and
prostate cancer growth, and identify molecular markers
that predict whether RU486 (or related drugs) will be
effective in particular prostate cancers in vivo. We have
now used chromatin immunoprecipitation to examine the
functional effects of RU486 mediated NCoR recruitment,
and find that NCoR is not mediating deacetylation and
hence not suppressing gene expression. The reason for
this is now under investigation. These results, in
conjunction with our previous data, reflect further
progress towards determining the structural basis for AR-
NCoR interaction (Aim 1) and determining whether this
interaction can be exploited to treat prostate cancer
(Aim 2).
Date Published: 2018-06-09 20:33:48
Identifier: DTIC_ADA463301
Item Size: 11009255
Language: english
Media Type: texts
# Topics
DTIC Archive; Balk, Steven P ; BETH I...
# Collections
dticarchive
additional_collections
# Uploaded by
@chris85
# Similar Items
View similar items
PHAROS
You are viewing proxied material from tilde.pink. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.